간염 검사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global hepatitis testing market size is expected to reach USD 6.64 Billion in 2034 from USD 4.14 Billion in 2025, growing at a CAGR of 5.39 during 2026-2034.This market is witnessing steady growth due to the increasing prevalence of hepatitis infections and the rising need for early diagnosis. Hepatitis B and C remain major global health concerns, prompting governments and healthcare organizations to implement screening programs. Early detection is crucial for effective treatment and prevention of disease transmission, which is driving the demand for reliable testing solutions.

Growth is fueled by advancements in diagnostic technologies, including rapid test kits and molecular diagnostics. These innovations offer faster and more accurate results, improving patient outcomes. Increasing awareness campaigns and government initiatives are encouraging individuals to undergo regular testing. The expansion of healthcare infrastructure, particularly in developing regions, is also supporting market growth. Additionally, the integration of point-of-care testing is making diagnostics more accessible.

Looking ahead, the market is expected to benefit from continued innovation in diagnostic methods and increased investment in healthcare systems. The development of cost-effective and portable testing solutions will further expand access. Emerging markets present significant opportunities due to rising awareness and improving medical facilities. The focus on disease elimination programs and preventive healthcare will continue to drive demand in the coming years.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Disease Type

• Hepatitis B (HBV)
• Hepatitis C (HCV)
• Others

By Technology

• Enzyme-linked Immunosorbent Assay (ELISA)
• Rapid Diagnostic Tests (RDT)
• Polymerase Chain Reaction (PCR)
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Others

By End User

• Hospital & Diagnostic Laboratories
• Blood Banks
• Others

COMPANIES PROFILED

• Abbott Laboratories, F. Hoffmann La Roche Ltd., Siemens Healthineers AG, Abbott Laboratories, Bio-Merieux, Danher Corporation, DiaSorin, Grifols SA, MedMira Inc, Ortho-Clinical Diagnostics, Qualpro Diagnostics, Roche Molecular Diagnostics, Siemens Healthcare, Sysmex Corporation

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEPATITIS TESTING MARKET: BY DISEASE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Disease Type
• 4.2. Hepatitis B (HBV) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Hepatitis C (HCV) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEPATITIS TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Enzyme-linked Immunosorbent Assay (ELISA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Rapid Diagnostic Tests (RDT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Polymerase Chain Reaction (PCR) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Isothermal Nucleic Acid Amplification Technology (INAAT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEPATITIS TESTING MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospital & Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Blood Banks Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEPATITIS TESTING MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Disease Type
  • 7.2.2 By Technology
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Disease Type
  • 7.3.2 By Technology
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Disease Type
  • 7.4.2 By Technology
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Disease Type
  • 7.5.2 By Technology
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Disease Type
  • 7.6.2 By Technology
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HEPATITIS TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott Laboratories
  • 9.2.2 F. Hoffmann La Roche Ltd
  • 9.2.3 Siemens Healthineers AG
  • 9.2.4 Abbott Laboratories
  • 9.2.5 Bio-Merieux
  • 9.2.6 Danher Corporation
  • 9.2.7 DiaSorin
  • 9.2.8 Grifols SA
  • 9.2.9 MedMira Inc
  • 9.2.10 Ortho-Clinical Diagnostics
  • 9.2.11 Qualpro Diagnostics
  • 9.2.12 Roche Molecular Diagnostics
  • 9.2.13 Siemens Healthcare
  • 9.2.14 Sysmex Corporation